Noninvasive Markers of Functional Nausea in Children (NCT03593811) | Clinical Trial Compass
CompletedEarly Phase 1
Noninvasive Markers of Functional Nausea in Children
United States42 participantsStarted 2018-08-03
Plain-language summary
The researchers propose to study how functional nausea in adolescents may be characterized noninvasively by the use of multichannel electrogastrogram (EGG) and magnetogastrogram (MGG) recordings.
Who can participate
Age range8 Years – 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* children ages 8-17 with functional nausea
* normal control participants ages 8-17 who have no known gastrointestinal complications
Exclusion Criteria:
* Those with claustrophobia who cannot lie still under the SQUID for the length of time required.
* Normal participants with known intestinal complications
* Patients with cyclic vomiting syndrome, gastroparesis, malignancy, primary eating disorders, pregnancy, or hyperglycemia
* Morbid obesity (these patients are presumably unable to lie under the current generation of SQUID devices).
* Patients with a history of cardiac arrhythmias or taking anticoagulants will be excluded